Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

NCT04149613 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

NCT NCT04149613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer
Lead sponsor
American University of Beirut Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 25, 2018
Completion date
July 15, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer stage iv